Meteora Capital
TDAC icon

Meteora Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Meteora Capital’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.8M Buy
919,000
+662,746
+259% +$7.08M 0.81% 39
2026
Q1 		$2.71M Sell
256,254
-14,589
-5% -$154K 0.2% 113
2025
Q4 		$2.83M Buy
+270,843
New +$2.82M 0.24% 94

Other funds holding TDAC

Linden Advisors
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Kryger Capital
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Alberta Investment Management Corp (AIMCo)
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Meteora Capital's TDAC Position: Q2 2026 in Review

Meteora Capital increased its Translational Development Acquisition Corp (TDAC) stake by 259% in Q2 2026, buying an estimated $7.08M and bringing the position to 919,000 shares worth $9.8M. The position accounts for 0.81% of the portfolio, ranked #39.

Meteora Capital first reported a position in TDAC in Q4 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Meteora Capital held 919,000 shares of Translational Development Acquisition Corp worth $9.8M as of Q2 2026.
  • Meteora Capital bought 662,746 Translational Development Acquisition Corp shares in Q2 2026, an estimated $7.08M.
  • Translational Development Acquisition Corp made up 0.81% of Meteora Capital's portfolio in Q2 2026, its #39 holding.
  • Meteora Capital first reported a position in Translational Development Acquisition Corp in Q4 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.